Seeing Is Believing
PACB is currently covered by 11 analysts with an average price target of $5.23. This is a potential upside of $3.54 (209.47%) from yesterday's end of day stock price of $1.69.
Pacific Biosciences of California's activity chart (see below) currently has 42 price targets and 64 ratings on display. The stock rating distribution of PACB is 63.64% BUY and 36.36% HOLD.
Analysts average stock forecasts to be materialized ratio is 64.85% with an average time for these price targets to be met of 221.23 days.
Highest price target for PACB is $15, Lowest price target is $2.5, average price target is $5.23.
Most recent stock forecast was given by RACHEL VATNSDAL from JPMORGAN on 22-Apr-2024. First documented stock forecast 27-Aug-2015.
Currently out of the existing stock ratings of PACB, 21 are a BUY (63.64%), 12 are a HOLD (36.36%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
16
10 days ago
1/2 (50%)
$4.48 (38.89%)
102
Hold
2.5
$0.81 (47.93%)
7
13 days ago
0/4 (0%)
$0.95 (61.29%)
Buy
8
$6.31 (373.37%)
15
14 days ago
2/4 (50%)
$6.54 (447.95%)
26
Buy
12
$10.31 (610.06%)
12.5
2 months 16 days ago
1/4 (25%)
$6.26 (109.06%)
109
Hold
4 months 19 days ago
3/3 (100%)
$-4.36 (-12.69%)
129
What is PACB (Pacific Biosciences of California) average time for price targets to be met?
Which analyst has the current highest performing score on PACB (Pacific Biosciences of California) with a proven track record?
Which analyst has the most public recommendations on PACB (Pacific Biosciences of California)?
Which analyst is the currently most bullish on PACB (Pacific Biosciences of California)?
Which analyst is the currently most reserved on PACB (Pacific Biosciences of California)?